Effect of the MyDefi Smartphone Application on Binge Drinking Among University Students: Protocol of a Double-Blind Multicenter Prospective National Randomized Controlled Trial Using Phosphatidylethanol as a Biomarker-The SMARTBINGE Trial.

ABSTRACT:

Objective

The purpose of this paper is to describe a study protocol of a clinical trial exploring the effectiveness of the new mobile application MyDéfi proposing personalized feedback, on both alcohol consumption and quality of life, as well as the blood alcohol exposure biomarker phosphatidylethanol, in university students displaying binge drinking behavior.

Methods

This prospective national multicentric randomized, two-arm (1:1), double-blind controlled trial will recruit 628 students (aged 18-25 years) with binge drinking behavior. Participants will be randomized in the "intervention" group (personalized feedback) or the "control" group (generic feedback) and will undergo four monthly visits. Monthly dried blood spot sample for measuring phosphatidylethanol concentration

SUBMITTER: Andre C 

PROVIDER: S-EPMC11959157 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature